Abstract 4353: Utilizing scRNA sequencing to understand biomarkers of response and resistance to Sacitizumab Govetican in localized TNBC
Clicks: 85
ID: 276794
2023
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
25.2
/100
85 views
27 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #24 of 40 articles by views in Cancer research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract is not available for this article.
Login to Search Abstract
| Reference Key |
peiris2023abstractcancer
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Peiris, Nicole;Cristea, Simona;Zhang, Mengran;Koh, Siang;Coates, James;Smidt, Ilze;Bossuyt, Veerle;Spring, Laura;Bardia, Aditya;Ellisen, Leif; |
| Journal | Cancer research |
| Year | 2023 |
| DOI |
10.1158/1538-7445.am2023-4353
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.